摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-carboxy-4-oxo-2-imidazolidinepropanoic acid | 126101-23-3

中文名称
——
中文别名
——
英文名称
2-carboxy-4-oxo-2-imidazolidinepropanoic acid
英文别名
2-carboxy-4-oxo-2-imidazolidine-propanoic acid;2-(2-carboxyethyl)-4-oxoimidazolidine-2-carboxylic acid
2-carboxy-4-oxo-2-imidazolidinepropanoic acid化学式
CAS
126101-23-3
化学式
C7H10N2O5
mdl
——
分子量
202.167
InChiKey
OCJZYNANYYCWKX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    627.8±55.0 °C(Predicted)
  • 密度:
    1.479±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -4
  • 重原子数:
    14
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    116
  • 氢给体数:
    4
  • 氢受体数:
    6

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-carboxy-4-oxo-2-imidazolidinepropanoic acid盐酸三甲基氯硅烷草酰氯N,N-二甲基甲酰胺六甲基二硅氮烷 作用下, 反应 6.17h, 生成 2,5-Dioxo-tetrahydro-pyrrolo[1,2-a]imidazole-7a-carbonyl chloride
    参考文献:
    名称:
    Synthesis and pharmacological activity of a series of dihydro-1H-pyrrolo[1,2-a]imidazole-2,5(3H,6H)-diones, a novel class of potent cognition enhancers
    摘要:
    A series of dihydro-1H-pyrrolo[1,2-a]imidazole-2,5(3H,6H)-diones were synthesized. These bicylic derivatives contain both the 2-pyrrolidinone and 4-imidazolidinone nuclei, already recognized as important for cognition enhancing activity. In addition, these structures maintain the backbone of piracetam and oxiracetam with the acetamide side chain restricted in a folded conformation. Their ability to reverse scopolamine-induced amnesia was assessed in a one trial, step-through, passive avoidance paradigm. The main features observed are a potent antiamnestic activity after ip administration (minimal effective dose being between 0.3 and 1 mg/kg ip for most compounds), the presence of a bell-shaped dose-response curve and, generally, a reduction of biological activity after po administration. However, the unsubstituted compound (15, dimiracetam) shows no evidence of a bell-shaped dose-response curve and completely retains activity when given orally, being 10-30 times more potent than the reference drug oxiracetam.
    DOI:
    10.1021/jm00078a011
  • 作为产物:
    描述:
    alpha-酮戊二酸甘氨酰胺盐酸盐sodium hydroxide 作用下, 以 为溶剂, 反应 4.0h, 以43%的产率得到2-carboxy-4-oxo-2-imidazolidinepropanoic acid
    参考文献:
    名称:
    Synthesis and pharmacological activity of a series of dihydro-1H-pyrrolo[1,2-a]imidazole-2,5(3H,6H)-diones, a novel class of potent cognition enhancers
    摘要:
    A series of dihydro-1H-pyrrolo[1,2-a]imidazole-2,5(3H,6H)-diones were synthesized. These bicylic derivatives contain both the 2-pyrrolidinone and 4-imidazolidinone nuclei, already recognized as important for cognition enhancing activity. In addition, these structures maintain the backbone of piracetam and oxiracetam with the acetamide side chain restricted in a folded conformation. Their ability to reverse scopolamine-induced amnesia was assessed in a one trial, step-through, passive avoidance paradigm. The main features observed are a potent antiamnestic activity after ip administration (minimal effective dose being between 0.3 and 1 mg/kg ip for most compounds), the presence of a bell-shaped dose-response curve and, generally, a reduction of biological activity after po administration. However, the unsubstituted compound (15, dimiracetam) shows no evidence of a bell-shaped dose-response curve and completely retains activity when given orally, being 10-30 times more potent than the reference drug oxiracetam.
    DOI:
    10.1021/jm00078a011
点击查看最新优质反应信息

文献信息

  • Condensed imidazole derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them.
    申请人:ISF SOCIETA PER AZIONI
    公开号:EP0335483A3
    公开(公告)日:1991-12-18
    Compounds of structure (I) in which, R¹ is hydrogen, C₁₋₄alkyl, CHR⁶CONHR⁷ or CHR⁶COOR⁷ in which R⁶ and R⁷ are each hydrogen or C₁₋₄alkyl; R² is hydrogen, C₁₋₅alkyl or a residue R² of an amino acid R² CH(NH₂)COOH; R³ is hydrogen, C₁₋₄alkyl, CONH₂ or CO₂R⁸ in which R⁸ is hydrogen or C₁₋₄alkyl; and n is 2, 3 or 4, processes for their preparation, intermediates useful in their preparation, pharmaceutical composition containing them and their use in therapy as nootropic agents.
    结构式(I)的化合物中,其中R¹为氢,C₁₋₄烷基,CHR⁶CONHR⁷或CHR⁶COOR⁷,其中R⁶和R⁷均为氢或C₁₋₄烷基;R²为氢,C₁₋₅烷基或氨基酸R² CH(NH₂)COOH的残基R²;R³为氢,C₁₋₄烷基,CONH₂或CO₂R⁸,其中R⁸为氢或C₁₋₄烷基;n为2、3或4,其制备方法,用于其制备的中间体,包含它们的制药组合物以及它们作为神经营养剂在治疗中的用途。
  • Psychotropic perhydroazacycloalka [1,2-A] imidazole derivatives
    申请人:I.S.F. Societa per Azioni
    公开号:US05053422A1
    公开(公告)日:1991-10-01
    Imidazole derivatives are described which are useful in restoring learning and treating memory difficulties. A compound of the invention is 2,5-dioxohexahydro-1H-pyrrolo[1,2-a]imidazole.
    描述了一种恢复学习能力和治疗记忆困难的咪唑衍生物。该发明的化合物是2,5-二氧代六氢-1H-吡咯[1,2-a]咪唑。
  • Pharmaceutically useful 2,5-dioxo-1H-octahydroimidazo[1,2-A]azepines
    申请人:I.S.F. Societa per Azioni
    公开号:US05200406A1
    公开(公告)日:1993-04-06
    Imidazole derivatives are described which are useful in restoring learning and treating memory difficulties. A compound of the invention is 2,5-dioxohexahydro-1H-pyrrolo[1,2-a]imidazole.
    本文描述了一种有益于恢复学习和治疗记忆障碍的咪唑衍生物。该发明的化合物是2,5-二氧代六氢-1H-吡咯并[1,2-a]咪唑。
  • Pharmacologically active 2,5-dioxo-octahydro-imidazo [1,2-a]pyridines
    申请人:I.S.F. Societa per Azioni
    公开号:US05130319A1
    公开(公告)日:1992-07-14
    Imidazole derivatives are described which are useful in restoring learning and treating memory difficulties. A compound of the invention is 2,5-dioxohexahydro-1H-pyrrolo[1,2-a]imidazole.
    本发明描述了一种有用于恢复学习和治疗记忆障碍的咪唑衍生物。本发明的一种化合物是2,5-二氧代六氢-1H-吡咯并[1,2-a]咪唑。
  • Pinza Mario, Farina Carlo, Cerri Alberto, Pfeiffer Ugo, Riccaboni Maria T+, J. Med. Chem, 36 (1993) N 26, S 4214-4220
    作者:Pinza Mario, Farina Carlo, Cerri Alberto, Pfeiffer Ugo, Riccaboni Maria T+
    DOI:——
    日期:——
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物